A Prospective Randomized Controlled Study of Long-Term Combination Therapy Using Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis and Dyslipidemia

B-Cell Depletion With Rituximab in Patients With Primary Biliary Cirrhosis Refractory to Ursodeoxycholic Acid

(2013) Robert P Myers et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

New Fibrate Use and Acute Renal Outcomes in Elderly Adults

(2013) Ying Y. Zhao   ANNALS OF INTERNAL MEDICINE

Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid

(2012) Akira Honda et al.   HEPATOLOGY

Efficacy of fenofibrate in Chinese patients with primary biliary cirrhosis partially responding to ursodeoxycholic acid therapy

(2012) Xiao Feng HAN et al.   Journal of Digestive Diseases

Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis

(2010) Teru Kumagi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

TNFSF9 expression in primary biliary cirrhosis and its clinical significance

(2010) Rong Xia et al.   CYTOKINE

Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid

(2009) Edith M.M. Kuiper et al.   GASTROENTEROLOGY

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

(2008) Christophe Corpechot et al.   HEPATOLOGY

The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study

(2008) Shinji Iwasaki et al.   HEPATOLOGY RESEARCH